Cargando…

Efficacy and safety of high-dose budesonide/formoterol in patients with bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplant

BACKGROUND: Bronchiolitis obliterans syndrome (BOS) is a rare, progressive and irreversible airway disease associated with significant mortality after allogeneic hematopoietic stem-cell transplantation (HSCT). In this study, we investigated the therapeutic effect of high-dose budesonide/formoterol (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Kyung Hoon, Lee, Jongmin, Kim, Hee-Je, Lee, Seok, Kim, Yoo-Jin, Lee, Jong Hyuk, Rhee, Chin Kook
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475605/ https://www.ncbi.nlm.nih.gov/pubmed/32944330 http://dx.doi.org/10.21037/jtd-19-3475

Ejemplares similares

Therapeutic effect of budesonide/formoterol, montelukast and N-acetylcysteine for bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation
por: Kim, Sei Won, et al.
Publicado: (2016)

Lung Transplantation for Bronchiolitis Obliterans after Allogeneic Hematopoietic Stem Cell Transplantation
por: Kim, Yu Ri, et al.
Publicado: (2012)

Risk Factor and Clinical Outcome of Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation
por: Rhee, Chin Kook, et al.
Publicado: (2016)

Bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: phenotypes and prognosis
por: Bergeron, A, et al.
Publicado: (2012)

Therapeutic effect of budesonide, montelukast and azithromycin on post-infectious bronchiolitis obliterans in children
por: Chen, Xia, et al.
Publicado: (2020)

Inhaled Bronchodilators and Corticosteroids in the Management of Bronchiolitis Obliterans due to Allogenic Hematopoietic Stem Cell Transplantation
por: Georgakopoulou, Vasiliki Epameinondas, et al.
Publicado: (2022)

Bronchiolitis Obliterans after Allogenic Bone Marrow Transplantation: HRCT Findings
por: Jung, Jung Im, et al.
Publicado: (2004)

Bronchiolitis obliterans
por: King, Talmadge E.
Publicado: (1989)

Postinfectious bronchiolitis obliterans in children: lessons from bronchiolitis obliterans after lung transplantation and hematopoietic stem cell transplantation
por: Yu, Jinho
Publicado: (2015)

Therapeutic comparison of a new budesonide/formoterol pMDI with budesonide pMDI and budesonide/formoterol DPI in asthma
por: Morice, A H, et al.
Publicado: (2007)

Bronchiolitis obliterans syndrome following SARS-CoV-2 infection in an allogeneic hematopoietic stem cell recipient
por: Bondeelle, Louise, et al.
Publicado: (2023)

Bronchiolitis Obliterans With Recurrent Pneumothorax After Allogeneic Bone Marrow Transplantation
por: Akatsuka, Masayuki, et al.
Publicado: (2023)

Quantitative CT and pulmonary function in children with post-infectious bronchiolitis obliterans
por: Kim, Jonghyeon, et al.
Publicado: (2019)

A Multicenter, Observational, Prospective Study of the Effectiveness of Switching from Budesonide/Formoterol Turbuhaler(®) to Budesonide/Formoterol Easyhaler(®)
por: Syk, Jörgen, et al.
Publicado: (2019)

Clinical analysis of adenovirus postinfectious bronchiolitis obliterans and nonadenovirus postinfectious bronchiolitis obliterans in children
por: Huang, Fei, et al.
Publicado: (2021)

Comparative Efficacy of Budesonide/Formoterol with Budesonide, Formoterol or Placebo for Stable Chronic Obstructive Pulmonary Disease: A Meta-Analysis
por: Tang, Bin, et al.
Publicado: (2019)

Correction to: A Multicenter, Observational, Prospective Study of the Effectiveness of Switching from Budesonide/Formoterol Turbuhaler(®) to Budesonide/Formoterol Easyhaler(®)
por: Syk, Jörgen, et al.
Publicado: (2019)

Beyond Bronchiolitis Obliterans: In-Depth Histopathologic Characterization of Bronchiolitis Obliterans Syndrome after Lung Transplantation
por: Vanstapel, Arno, et al.
Publicado: (2021)

Early Pathologic Findings of Bronchiolitis Obliterans after Allogeneic Hematopoietic Stem Cell Transplantation: A Proposal from a Case
por: Nakamoto-Matsubara, Rie, et al.
Publicado: (2012)

Budesonide–formoterol (inhalation powder) in the treatment of COPD
por: Ceylan, Erkan
Publicado: (2006)

Comparison of Aerosol Formulations of Formoterol Fumarate and Budesonide
por: Nirale, N. M., et al.
Publicado: (2011)

Budesonide/Glycopyrronium/Formoterol: A Review in COPD
por: Heo, Young-A
Publicado: (2021)

Protocol: Influence of Budesonide and Budesonide/Formoterol on Asthma Control in Smoking Asthmatic Adults
por: Boulet, Louis-Philippe, et al.
Publicado: (2010)

Lung Clearance Index and Quantitative Computed Tomography of Post-Infectious Bronchiolitis Obliterans in Infants
por: Kim, Yoon Hee, et al.
Publicado: (2017)

S290: DEVELOPMENT AND VALIDATION OF A PROGNOSTIC MODEL OF BRONCHIOLITIS OBLITERANS SYNDROME IN ADULT PATIENTS FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Huang, Qiu-Sha, et al.
Publicado: (2023)

Mycoplasma pneumoniae–Associated Bronchiolitis Obliterans Following Acute Bronchiolitis
por: Zhao, Chengsong, et al.
Publicado: (2017)

Follow-up on the therapeutic effects of a budesonide, azithromycin, montelukast, and acetylcysteine (BAMA) regimen in children with post-infectious bronchiolitis obliterans
por: Weng, Tingting, et al.
Publicado: (2021)

Quantitative CT lung densitometry as an obstructive marker for the diagnosis of bronchiolitis obliterans in children
por: Lee, Hye Jin, et al.
Publicado: (2022)

Dermatomyositis without Elevation of Creatine Kinase Presented as Bronchiolitis Obliterans Organizing Pneumonia
por: Lee, Young Ho, et al.
Publicado: (2000)

Exposure-Response and Clinical Outcome Modeling of Inhaled Budesonide/Formoterol Combination in Asthma Patients
por: Back, Hyun-moon, et al.
Publicado: (2020)

Budesonide/formoterol combination in COPD: a US perspective
por: Sharafkhaneh, Amir, et al.
Publicado: (2010)

Tolerability of budesonide/formoterol in patients of Kazakhstan rural regions
por: Nurpeissov, Tair, et al.
Publicado: (2015)

Correction to: Budesonide/Glycopyrronium/Formoterol: A Review in COPD
por: Heo, Young-A
Publicado: (2021)

A Case of Bronchiolitis Obliterans Organizing Pneumonia Associated with Adenovirus
por: Jeon, Jin Seok, et al.
Publicado: (1997)

Temozolomide-Associated Bronchiolitis Obliterans Organizing Pneumonia Successfully Treated with High-Dose Corticosteroid
por: Kim, Tae-Ok, et al.
Publicado: (2012)

Analysis of Risk Factors of Bronchiolitis Obliterans in Children with Mycoplasma pneumoniae Bronchiolitis
por: Huang, KunLing, et al.
Publicado: (2022)

Rituximab-Induced Bronchiolitis Obliterans Organizing Pneumonia
por: Ergin, Ahmet B., et al.
Publicado: (2012)

Upregulation of elastin expression in constrictive bronchiolitis obliterans
por: Shifren, Adrian, et al.
Publicado: (2007)

Quinine-induced bronchiolitis obliterans and organizing pneumonia
por: Rahman, Masoodur, et al.
Publicado: (2012)

Bortezomib-Induced Bronchiolitis Obliterans Organizing Pneumonia
por: Vandeix, E., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ttgf8t5age8q4bivdjrh2acooe